Clinical severity spectrum of re-infected cov-19 patients in Khyber Pakhtunkhuwa (KPK)
Abstract
Background: Re-infection is infection likely to occurred second time. Recently due to
increase in the pandemic of SARS COV-2 there were increased in cases of re-infection but
the clinically severity spectrum of re-infection is unknown. This study is design to determine
clinical severity of re-infected COV-19 patients. Material and methodology: This
comparative cross-sectional study was conducted in pathology department of Rehman
Medical Institute Peshawar Pakistan and Leady Reading Hospital Peshawar within duration
of 6 months (February-July 2021). Inclusion criteria: Patients who were re-infected by SARS
COV-2 and having duration between primary infection and re-infection are > 30 days were
included. Exclusion criteria: Unwilling patient to give data and patients having duration
between primary infection and re-infection is<30 days were excluded from the study. Sample
size: Total 32 samples were collected by designing proper Questionnaire according to the
criteria of (World Health Organization). The collected data will be analyzed through SPSS
version 22. The frequencies, mean, standard deviation of data was performed by descriptive
statistics in SPSS. Result: Out of 32 primary SARS COV-2 infected individuals, 20 have
mild infection while in same 32 re-infected SARS COV-2 individuals 19 individuals have
severe symptoms in its secondary infection with mean age (32years) of individuals.
Conclusion: In current study by comparing primary symptoms of SARS COV-2 infected
individuals with symptoms of Re-infected individuals, symptoms are mild and severe
respectively. Hence, re-infection cause by SARS COV-2 is more severe than primary
infection
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 International Journal of Natural Medicine and Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
• Share: copy and redistribute the material in any medium or format.
• Adapt: remix, transform, and build upon the material.
• Attribution: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• NonCommercial: You may not use the material for commercial purposes.
• No additional restrictions: You may not apply legal terms or technological measures, that legally restrict others from doing anything the license permits.